ALNXT Fundamental Analysis - NEXTEDIA

Fundamental Rating

Taking everything into account, ALNXT scores 5 out of 10 in our fundamental rating. ALNXT was compared to 76 industry peers in the IT Services industry. The financial health of ALNXT is average, but there are quite some concerns on its profitability. ALNXT may be a bit undervalued, certainly considering the very reasonable score on growth

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year ALNXT was profitable.

In the past year ALNXT had a positive cash flow from operations.

Each year in the past 5 years ALNXT has been profitable.

ALNXT had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

With a Return On Assets value of 2.83%, ALNXT perfoms like the industry average, outperforming 43.42% of the companies in the same industry.

ALNXT has a Return On Equity of 4.93%. This is comparable to the rest of the industry: ALNXT outperforms 40.79% of its industry peers.

ALNXT's Return On Invested Capital of 6.30% is on the low side compared to the rest of the industry. ALNXT is outperformed by 61.84% of its industry peers.

ALNXT had an Average Return On Invested Capital over the past 3 years of 6.20%. This is significantly below the industry average of 26.78%.

The last Return On Invested Capital (6.30%) for ALNXT is above the 3 year average (6.20%), which is a sign of increasing profitability.

		Industry Rank	Sector Rank
ROA	2.83%
ROE	4.93%
ROIC	6.3%

ROA(3y)2.64%

ROA(5y)3.08%

ROE(3y)5.31%

ROE(5y)6.42%

ROIC(3y)6.2%

ROIC(5y)6.1%

1.3 Margins

ALNXT has a Profit Margin (2.50%) which is comparable to the rest of the industry.

In the last couple of years the Profit Margin of ALNXT has declined.

ALNXT has a Operating Margin (5.15%) which is comparable to the rest of the industry.

In the last couple of years the Operating Margin of ALNXT has declined.

With a Gross Margin value of 54.19%, ALNXT is not doing good in the industry: 60.53% of the companies in the same industry are doing better.

In the last couple of years the Gross Margin of ALNXT has declined.

		Industry Rank	Sector Rank
OM	5.15%
PM (TTM)	2.5%
GM	54.19%

OM growth 3Y-10.16%

OM growth 5Y-2.26%

PM growth 3Y-8.02%

PM growth 5Y-2.63%

GM growth 3Y-8.46%

GM growth 5Y-11.02%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ALNXT is destroying value.

Compared to 1 year ago, ALNXT has about the same amount of shares outstanding.

Compared to 5 years ago, ALNXT has more shares outstanding

The debt/assets ratio for ALNXT has been reduced compared to a year ago.

2.2 Solvency

An Altman-Z score of 2.14 indicates that ALNXT is not a great score, but indicates only limited risk for bankruptcy at the moment.

ALNXT has a Altman-Z score of 2.14. This is in the lower half of the industry: ALNXT underperforms 60.53% of its industry peers.

ALNXT has a debt to FCF ratio of 3.10. This is a good value and a sign of high solvency as ALNXT would need 3.10 years to pay back of all of its debts.

With a Debt to FCF ratio value of 3.10, ALNXT perfoms like the industry average, outperforming 57.89% of the companies in the same industry.

A Debt/Equity ratio of 0.12 indicates that ALNXT is not too dependend on debt financing.

ALNXT has a better Debt to Equity ratio (0.12) than 81.58% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.12
Debt/FCF	3.1
Altman-Z	2.14

ROIC/WACC0.95

WACC6.65%

2.3 Liquidity

ALNXT has a Current Ratio of 1.25. This is a normal value and indicates that ALNXT is financially healthy and should not expect problems in meeting its short term obligations.

ALNXT's Current ratio of 1.25 is in line compared to the rest of the industry. ALNXT outperforms 53.95% of its industry peers.

ALNXT has a Quick Ratio of 1.25. This is a normal value and indicates that ALNXT is financially healthy and should not expect problems in meeting its short term obligations.

Looking at the Quick ratio, with a value of 1.25, ALNXT is in the better half of the industry, outperforming 61.84% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	1.25
Quick Ratio	1.25

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 39.79% over the past year.

ALNXT shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 3.66% yearly.

Looking at the last year, ALNXT shows a decrease in Revenue. The Revenue has decreased by -2.25% in the last year.

The Revenue has been growing by 21.48% on average over the past years. This is a very strong growth!

EPS 1Y (TTM)39.79%

EPS 3Y-3.66%

EPS 5Y3.66%

EPS Q2Q%4.76%

Revenue 1Y (TTM)-2.25%

Revenue growth 3Y8.74%

Revenue growth 5Y21.48%

Sales Q2Q%-8.17%

3.2 Future

Based on estimates for the next years, ALNXT will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.47% on average per year.

Based on estimates for the next years, ALNXT will show a quite strong growth in Revenue. The Revenue will grow by 8.18% on average per year.

EPS Next Y20.64%

EPS Next 2Y9.47%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year13.87%

Revenue Next 2Y8.18%

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 10.50 indicates a reasonable valuation of ALNXT.

Compared to the rest of the industry, the Price/Earnings ratio of ALNXT indicates a rather cheap valuation: ALNXT is cheaper than 93.42% of the companies listed in the same industry.

Compared to an average S&P500 Price/Earnings ratio of 26.57, ALNXT is valued rather cheaply.

Based on the Price/Forward Earnings ratio of 4.53, the valuation of ALNXT can be described as very cheap.

Compared to the rest of the industry, the Price/Forward Earnings ratio of ALNXT indicates a rather cheap valuation: ALNXT is cheaper than 94.74% of the companies listed in the same industry.

Compared to an average S&P500 Price/Forward Earnings ratio of 24.04, ALNXT is valued rather cheaply.

		Industry Rank	Sector Rank
PE	10.5
Fwd PE	4.53

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, ALNXT is valued a bit cheaper than the industry average as 78.95% of the companies are valued more expensively.

		Industry Rank	Sector Rank
P/FCF	8.97
EV/EBITDA	N/A

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

PEG (NY)0.51

PEG (5Y)2.87

EPS Next 2Y9.47%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

ALNXT does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

NEXTEDIA

EPA:ALNXT (12/24/2025, 7:00:00 PM)

0.42

+0.01 (+2.69%)

Chartmill FA Rating

GICS SectorInformation Technology

GICS IndustryGroupSoftware & Services

GICS IndustryIT Services

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst OwnersN/A

Inst Owner ChangeN/A

Ins Owners17.68%

Ins Owner ChangeN/A

Market Cap16.38M

Revenue(TTM)62.04M

Net Income(TTM)1.55M

AnalystsN/A

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	10.5
Fwd PE	4.53
P/S	0.26
P/FCF	8.97
P/OCF	8.57
P/B	0.52
P/tB	14.13
EV/EBITDA	N/A

EPS(TTM)0.04

EY9.52%

EPS(NY)0.09

Fwd EY22.07%

FCF(TTM)0.05

FCFY11.14%

OCF(TTM)0.05

OCFY11.67%

SpS1.59

BVpS0.81

TBVpS0.03

PEG (NY)0.51

PEG (5Y)2.87

Graham Number0.85

Profitability

		Industry Rank	Sector Rank
ROA	2.83%
ROE	4.93%
ROCE	8.85%
ROIC	6.3%
ROICexc	7.81%
ROICexgc	N/A
OM	5.15%
PM (TTM)	2.5%
GM	54.19%
FCFM	2.94%

ROA(3y)2.64%

ROA(5y)3.08%

ROE(3y)5.31%

ROE(5y)6.42%

ROIC(3y)6.2%

ROIC(5y)6.1%

ROICexc(3y)8.02%

ROICexc(5y)8.4%

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)8.71%

ROCE(5y)8.58%

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3Y-9.69%

ROICexc growth 5Y-0.48%

OM growth 3Y-10.16%

OM growth 5Y-2.26%

PM growth 3Y-8.02%

PM growth 5Y-2.63%

GM growth 3Y-8.46%

GM growth 5Y-11.02%

F-Score7

Asset Turnover1.13

Health

		Industry Rank	Sector Rank
Debt/Equity	0.12
Debt/FCF	3.1
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	0.14%
Interest Coverage	250
Cash Conversion	N/A
Profit Quality	117.82%
Current Ratio	1.25
Quick Ratio	1.25
Altman-Z	2.14

F-Score7

WACC6.65%

ROIC/WACC0.95

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)0.47%

Cap/Sales(5y)0.35%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)39.79%

EPS 3Y-3.66%

EPS 5Y3.66%

EPS Q2Q%4.76%

EPS Next Y20.64%

EPS Next 2Y9.47%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-2.25%

Revenue growth 3Y8.74%

Revenue growth 5Y21.48%

Sales Q2Q%-8.17%

Revenue Next Year13.87%

Revenue Next 2Y8.18%

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y5.19%

EBIT growth 3Y-2.31%

EBIT growth 5Y18.73%

EBIT Next Year22.44%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-22.12%

FCF growth 3Y-11.08%

FCF growth 5YN/A

OCF growth 1Y-33.44%

OCF growth 3Y-10.82%

OCF growth 5YN/A

NEXTEDIA / ALNXT.PA FAQ

Can you provide the ChartMill fundamental rating for NEXTEDIA?

ChartMill assigns a fundamental rating of 5 / 10 to ALNXT.PA.

Can you provide the valuation status for NEXTEDIA?

ChartMill assigns a valuation rating of 7 / 10 to NEXTEDIA (ALNXT.PA). This can be considered as Undervalued.

What is the profitability of ALNXT stock?

NEXTEDIA (ALNXT.PA) has a profitability rating of 3 / 10.

Can you provide the financial health for ALNXT stock?

The financial health rating of NEXTEDIA (ALNXT.PA) is 5 / 10.

What is the expected EPS growth for NEXTEDIA (ALNXT.PA) stock?

The Earnings per Share (EPS) of NEXTEDIA (ALNXT.PA) is expected to grow by 20.64% in the next year.

NEXTEDIA (ALNXT.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

NEXTEDIA / ALNXT.PA FAQ

Can you provide the ChartMill fundamental rating for NEXTEDIA?

Can you provide the valuation status for NEXTEDIA?

What is the profitability of ALNXT stock?

Can you provide the financial health for ALNXT stock?

What is the expected EPS growth for NEXTEDIA (ALNXT.PA) stock?